Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 10 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 24,415 followers.

Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma https://t.co/QbY9C9e9vN

04 Nov 2022

Reply Repost Favourite

Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma https://t.co/dzIn2XG7Rt

03 Nov 2022

Reply Repost Favourite

Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma: We aimed to develop and validate a pyradiomics model for… #oncology https://t.co/

19 Oct 2022

Reply Repost Favourite

New research: Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma: We aimed to develop and validate a pyradiomics model for… https://t.

17 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.